Vendor, Dixon, CA
Hemostat Laboratories, Inc.
UEI TG1BHPWFLZL5, CAGE 08BU0
1 award and $0 obligated between April 17, 2024 and June 9, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Not Competed | 1 |
| Purchase Order | 1 |
Hear when Hemostat Laboratories, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Hemostat Laboratories, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $0
- Soonest
- September 21, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling in-vitro diagnostic substance manufacturing to Centers for Disease Control and Prevention, by dollars.
| Biosearch Technologies, Inc.Petaluma, CA | $1,243,300 |
| Seegene Usa, Inc.Irvine, CA | $179,440 |
| MX3 Diagnostics, Inc.Austin, TX | $131,374 |
| Ab Diagnostic Systems GMBHBerlin | -$41,776 |
| Premier Medical USA Corp.Somerset, NJ | -$75,680 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75D30123P17076Purchase Order, April 17, 2024, Not Competed, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Laboratory Samples and SuppliesNAICS 325413, PSC R499 | $0 |
- Places of performance
- Georgia
- Product and service codes
- R499 Other Professional Services
- Transactions
- 2 across 1 awards